Cancer Prevention
Researchers provide details of new studies and findings in the area of cancer prevention
Published in Gastroenterology Week, November 21st, 2005
Study 1: Interferon-alpha lowers proliferative activity in hepatitis C-infected livers.
According to recent research published in the Journal of Viral Hepatitis, "interferon (IFN) therapy has been shown to reduce the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis C, including virological nonresponders (NR). Whether IFN suppresses liver cell proliferation, i.e. the relevant risk factor for HCC, is unknown."
"The aim of the study was to evaluate the effect of IFN therapy on liver cell proliferation in chronic hepatitis C. The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gastroenterology Week
More Articles from Gastroenterology Week
- Crohn Disease
Endoscopic camera pill proves to be effective tool for diagnosing Crohn disease - Disease Associations
Overweight patients bear a higher risk for developing acute liver failure - Drug Safety
High doses of ibuprofen can cause significant GI bleeding despite its safety profile - Gastroenterology
Infectious diarrhea is a major cause of childhood mortality in developing countries - Liver Cancer
Synthetic oleanolic acid reduced the growth of liver tumors in animal model - Adverse Drug Reaction
Patients develop acute liver failure after receiving amoxicillin/clavulanate - More from this issue of Gastroenterology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
